The Center for Genetic Engineering and Biotechnology (CIGB) ratified that Nasalferon, a drug developed in Cuba against Covid-19, is safe and well tolerated.
The drug, which strengthens the immune system, and is administered nasally in a prophylactic scheme with a drop in each nostril twice a day for 10 days, can reduce the risk of severe symptoms in people with Covid-19,” the CIGB wrote on its Twitter account.
This preparation is an antiviral, immunomodulatory and prophylactic product, and it can be used against different acute respiratory diseases.
It is a formulation of recombinant human Alpha-2b-interferon for nasal administration, whose immunomodulatory and antiviral properties prevent the replication of the SARS-CoV-2 coronavirus, which causes Covid-19, and strengthen the immune system, the text added.
Of proven safety, this drug had a leading role when the Delta strain of the coronavirus was found in Cuba and it was necessary to increase the population’s defensive response.
(With information from Prensa Latina)
CubaPLUS Latinos
CubaPLUS Guyana
CubaPLUS Travel